Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Mehra

Showing results (201-210 of 347) with videos related to

Pageof 35
Sort By:
Oncotarget|May 14, 2016
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancerYusuke Shiozawa, Janice E Berry, Matthew R Eber, et al.
Urologic Oncology|November 10, 2021
Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimenNicholas W Eyrich, John T Wei, Yashar S Niknafs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profileJudy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Human Pathology|April 29, 2014
Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlationsJoshua I Warrick, Alex Tsodikov, Lakshmi P Kunju, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA <i>In Situ</i> Hybridization AssayLisha Wang, Paul W Harms, Nallasivam Palanisamy, et al.
The New England Journal of Medicine|September 24, 2005
Autoantibody signatures in prostate cancerXiaoju Wang, Jianjun Yu, Arun Sreekumar, et al.
Research Square|October 3, 2025
Molecular Profiling of Primary versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma Reveals Heterogeneity in Tumor Immune MicroenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
Neoplasia (New York, N.Y.)|March 15, 2025
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancerAnbarasu Kumaraswamy, Rahul Mannan, Olivia A Swaim, et al.
Medical Oncology (Northwood, London, England)|July 24, 2019
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution seriesJohn M Kennedy, Xiaoming Wang, Komal R Plouffe, et al.
Cancer Research|April 17, 2012
Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancerGang Ren, Stavroula Baritaki, Himangi Marathe, et al.
Pageof 35

Showing results (201-210 of 347) with videos related to

Sort By:
Pageof 35
Oncotarget|May 14, 2016
The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancerYusuke Shiozawa, Janice E Berry, Matthew R Eber, et al.
Urologic Oncology|November 10, 2021
Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimenNicholas W Eyrich, John T Wei, Yashar S Niknafs, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 10, 2019
Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profileJudy Sarungbam, Rohit Mehra, Scott A Tomlins, et al.
Human Pathology|April 29, 2014
Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlationsJoshua I Warrick, Alex Tsodikov, Lakshmi P Kunju, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Age and Gender Associations of Virus Positivity in Merkel Cell Carcinoma Characterized Using a Novel RNA <i>In Situ</i> Hybridization AssayLisha Wang, Paul W Harms, Nallasivam Palanisamy, et al.
The New England Journal of Medicine|September 24, 2005
Autoantibody signatures in prostate cancerXiaoju Wang, Jianjun Yu, Arun Sreekumar, et al.
Research Square|October 3, 2025
Molecular Profiling of Primary versus Paired Asynchronous Metastatic Clear Cell Renal Cell Carcinoma Reveals Heterogeneity in Tumor Immune MicroenvironmentBrittney Cotta, Srinivas Nallandhighal, Steven Monda, et al.
Neoplasia (New York, N.Y.)|March 15, 2025
LSD1+8a is an RNA biomarker of neuroendocrine prostate cancerAnbarasu Kumaraswamy, Rahul Mannan, Olivia A Swaim, et al.
Medical Oncology (Northwood, London, England)|July 24, 2019
Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution seriesJohn M Kennedy, Xiaoming Wang, Komal R Plouffe, et al.
Cancer Research|April 17, 2012
Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancerGang Ren, Stavroula Baritaki, Himangi Marathe, et al.
Pageof 35